The successful competitive renewal of our Center for Iron and Heme Disorders (CIHD) grant from the NIDDK contains funds to continue Pilot and Feasibility awards. We welcome P&F grants for this next fiscal year. Proposals are due August 10, 2021 and following competitive evaluations, three awards for $33,000 will be awarded September 1, 2021. The funds must be expended by July 31, 2022. The awards will be for one single year with no second-year extensions. The goals of the CIHD are to support research on molecular/cellular biological pathways involved in normal hematopoietic stem cell biology, erythroid differentiation and disease states in addition to iron and heme biology.

 

The stipulations for the CIHD P&F awards are as follows:

  1. CIHD members are entitled to apply with a proposal distinct from any previous CIHD proposals from past funding periods.
  2. CIHD members from outside Utah are welcome to apply if they have an active collaboration with a Utah member of the CIHD.
  3. A Principal Investigator (PI) must be a tenure track or research track faculty with an appointment of at least 0.75 FTE. Research faculty must have had a two-year residency at their institution prior to funding applications. Proposals that have previously been submitted to an extramural agency and found to be non-competitive will not be reviewed.
  4. All successful applicants for funding will be asked to present an update of their research at a spring 2022 CIHD symposium.

Checklist for submission

  1. Abstract: 1 separate page
  2. 3 pages of project description: significance, background and proposed studies
  3. Statement of relevance to our CIHD
  4. Description of CIHD cores to be utilized
  5. NIH-style biosketch
  6. Current and pending support
  7. Proposed budget and justification ($33,000 maximal budget)
  8. NIH grant submission plans

Applications should be submitted as pdf files to dennis.winge@hsc.utah.edu and john.phillips@hsc.utah.edu